BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses | Zendy

S.-R. Shih | Zendy; JimTong Horng | Zendy; Leo L. M. Poon | Zendy; TunChieh Chen | Zendy; J. Y. Yeh | Zendy; HsingPang Hsieh | Zendy; Sung-Nain Tseng | Zendy; Chih-Po Chiang | Zendy; W.-L. Li | Zendy; Y S Chao | Zendy; John Hsu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses

Author(s) -

S.-R. Shih,

JimTong Horng,

Leo L. M. Poon,

TunChieh Chen,

J. Y. Yeh,

HsingPang Hsieh,

Sung-Nain Tseng,

Chih-Po Chiang,

W.-L. Li,

Y S Chao,

John Hsu

Publication year - 2009

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkp393

Subject(s) - oseltamivir , virology , virus , influenza a virus , ribonucleoprotein , orthomyxoviridae , neuraminidase inhibitor , biology , antiviral drug , medicine , covid-19 , infectious disease (medical specialty) , rna , genetics , gene , disease , pathology

The emergence of oseltamivir-resistant viruses raised the global threat with regard to influenza virus infection. To develop alternative antiviral agents against influenza virus infection is significant and urgent.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research